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Abstract
Background: Oyaksungisan (OY) has been used as a traditional drug in east-Asian countries. However, its effect on
inflammation still remains unknown. In this study, to provide insight into the biological effects of OY and OY
fermented by Lactobacillus, we investigated their effects on lipopolysaccharide (LPS)-mediated inflammation in the
RAW 264.7 murine macrophage cells.
Methods: The investigation was focused on whether OY and fermented OYs could inhibit the production of pro-
inflammatory mediators such as nitric oxide (NO) and prostaglandin (PG) E2 as well as the expression of inducible
nitric oxide synthase (iNOS), cyclooxygenase (COX)-2, tumor necrosis factor (TNF)-a, interleukin (IL)-6, nuclear factor
(NF)-B and mitogen-activated protein kinases (MAPKs) in LPS-stimulated RAW 264.7 cells.
Results: We found that OY inhibits a little LPS-induced NO, PGE2, TNF-a and IL-6 productions as well as the
expressions of iNOS and COX-2. Interestingly, the fermentation significantly increased its inhibitory effect on the
expression of all pro-inflammatory mediators. Furthermore, the fermented OYs exhibited elevated inhibition on the
translocation of NF-B p65 through reduced IBa degradation as well as the phosphorylations of extracellular
signal-regulated kinase (ERK), p38 and c-Jun NH2-terminal kinase (JNK) MAPKs than untreated control or original
OY.
Conclusions: Finally, the fermentation by Lactobacillus potentiates the anti-inflammatory effect of OY by inhibiting
NF-B and MAPK activity in the macrophage cells.
Background
Oyaksungisan (OY) is a traditional herbal medication
that consists of twelve herbs and is known to have anti-
arthralgia, anti-paralysis and anti-dizziness effects. Since
ancient times, OY has been widely used as a traditional
medication in Asian countries. More specifically, it has
been prescribed for the treatment of beriberi, vomiting,
diarrhea and circulatory disturbance.
Recent studies have demonstrated that OY inhibits the
adjuvant arthritis in rat [1] and OY has neuroprotective
activity [2]. It was also reported that OY exerts the pro-
tective effect against H2O2-induced apoptosis [3] and
other studies have revealed the anti-inflammatory effect
in peripheral blood mononuclear cells from cerebral
infarction patients [4]. However, the effect and mechan-
ism of OY or fermented OYs on macrophage-mediated
inflammation still remain unknown.
The fermented plant products are abundant in antiox-
idants similar to butylated hydroxyanisole and green tea
[5]. During the process of fermentation by Lactobacillus,
organic acids are amassed, proteins are hydrolyzed and
antioxidant ferulic acid from plant cell wall materials
are solubilized [6,7]. When the grain foods once were
fermented with Aspergillus oryzae, strong antioxidant
destroying free radicals were formed [8]. Those fermen-
ted plant products could contain antioxidative activities
and anti-inflammatory activities, which can be used as a * Correspondence: jyma@kiom.re.kr
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from diseases like cancer and HIV [9].
Inflammation is an early host immune reaction
mediated by cytokines secreted from immune cells. Var-
ious in vitro and in vivo experimental models have been
established to assess the inhibitory effects of naturally
derived products on the synthesis and release of inflam-
matory cytokines and other inflammatory mediators
including NO and PGE2, which are synthesized by iNOS
and COX-2, respectively [10,11]. LPS is one of well-
known inflammatory ligands to stimulate macrophages
to release various inflammatory cytokines. These inflam-
matory cytokines are essential for host survival following
infection and are also required for the repair of tissue
injuries [11]. Of these pro-inflammatory cytokines,
TNF-a and IL-6 are known to be important inflamma-
tory mediators involved in the development of a number
of inflammatory diseases.
Macrophages play an important role in host defenses
against noxious substances and are involved in a variety
of disease processes including autoimmune diseases,
infections, and inflammatory disorders [12]. Various
inflammatory mediators are involved in the pathogenesis
of many inflammation-associated human diseases
[13,14]. The expression of these cytokine genes can be
regulated by the activation of the NF-B, which is criti-
cally involved in the pathogenesis of rheumatoid arthri-
tis and other chronic inflammatory diseases [15].
Usually, p65 of NF-B is tightly sequestered by IBa in
the cytosol but when immunostimulatory ligands like
LPS activate the cells, p65 is released from the phos-
phorylated IBa by IBa kinase and subsequent IBa
degradation [16]. The liberated NF-B then translocates
from cytosol into nuclei and transactivates the promoter
of pro-inflammatory genes such as iNOS, COX-2 and
IL-6. Most anti-inflammatory drugs suppress the expres-
sion of these pro-inflammatory genes by inhibiting the
NF-B activation pathway [17].
In addition, MAPKs phosphorylation is related to
induce NF-B activation and to stimulate iNOS gene
expression. Several reports showed specific MAPK inhi-
bitors suppress iNOS gene expression [18-20].
Here, we first demonstrate the inhibitory effect of OY
and fermented OYs on LPS-induced inflammation in
RAW 264.7 macrophage cells by evaluating the expres-
sion of pro-inflammatory mediators and furthermore,
OY fermented by Lactobacillus exhibit strong anti-
inflammatory activity by repressing pro-inflammatory
mediators via regulating NF-B and MAPK signaling.
Methods
Materials and reagents
RPMI 1640, penicillin, and streptomycin were obtained
from Hyclone (Logan, UT, USA). Bovine serum
albumin, LPS and 3-(4,5-dimethylthiazol-2-yl)-2,5-diphe-
nylthiazolium bromide (MTT) were purchased from
Sigma (St. Louis, MO, USA). COX-2, iNOS antibodies
were purchased from Abcam (Cambridge, UK). b-actin,
p38, phospho-p38, ERK, phospho-ERK, JNK, phospho-
JNK and p65 monoclonal antibodies were purchased
from cell signaling technology, Inc. (Boston, MA, USA).
Peroxidase-conjugated secondary antibodies were
obtained from Santa Cruz Biotechnology Inc. (Santa
Cruz, CA, USA) and TNF-a, IL-6 antibody, biotinylated
TNF-a and IL-6 antibodies were purchased from BD
Biosciences (San Jose, CA, USA). An RNA extraction kit
was purchased from iNtRON Biotech (Daejeon, Korea).
The primers specific for COX-2, iNOS, IL-6, and b-
actin were synthesized by Bioneer Corp. (Daejeon,
Korea). Poncirin was obtained from the Korea Food &
Drug Administration (Cheongwon, Korea) and Hesperi-
din was purchased from ICN Co. (Costa Mesa, CA,
USA). Glycyrrhizin was purchased from TCI Co.
(Tokyo, Japan) and Rutin and Naringin were purchased
f r o mS i g m aC h e m i c a lC o .( S t .L o u i s ,M O ,U S A ) .H P L C
grade solutions, water, acetonitrile, and glacial acetic
acid were purchased from J.T. Baker (Austin, TX, USA).
Preparation of OY and fermented OYs
The OY is composed of Ephedra Herb, Citrus Unshiu
Peel, Lindera Root, Cnidii Rhizoma, Angelica Dahurica
Root, Batryticatus Bombyx, Aurantii Fructus Immaturus,
Platycodon Root, Zingiberis Rhizoma, Glycyrrhizae
Radix et Rhizoma, Zingiberis Rhizoma Crudus, Zizyphi
Fructus, which were purchased from Yeongcheon Orien-
tal Herbal Market (Yeongcheon, Korea). All voucher
specimens were deposited in the herbal bank and placed
in 22,345 mL of distilled water and then extracted by
heating for 3 hours at 115°C (Gyeongseo Extractor Cos-
m o s - 6 0 0 ,I n c h o n ,K o r e a ) .A f t e re x t r a c t i o n ,t h eO Yw a s
filtered out using standard testing sieves (150 μm)
(Retsch, Haan, Germany). The OY was incubated with
Lactobacilluses (1-5 × 10
8 C F U / m L )o b t a i n e df r o mt h e
KFRI (Korea Food Research Institute, Sungnam, Korea)
to prepare fermented OYs. Before use, the bacterial
strain was incubated in 50 mL of MRS broth (DifcoTM
Lactobacilli MRS Broth, Becton Dickinson, Franklin
L a k e s ,N J ,U S A )a t3 7 ° Co v e r n i g h t .T h eO Yf e r m e n t e d
by Lactobacilluses at 37°C for 48 hours was filtered with
a 60-μm nylon net filter (Millipore, Billerica, MA, USA),
lyophilized, and stored in desiccators at 4°C. The freeze-
dried extract powder was then dissolved in phosphate
buffered saline (PBS) and filtered (pore size, 0.45 μm),
lyophilized and kept at 4°C prior to use.
Cell culture
The murine macrophage cell RAW 264.7 was obtained
from the Korea Cell Line Bank (Seoul, Korea) and
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bovine serum and 100 U/mL of penicillin/streptomycin
sulfate. The cells were incubated in a humidified 5%
CO2 atmosphere at 37°C [21]. To stimulate the cells, the
medium was replaced with fresh RPMI 1640 medium
with 200 ng/mL LPS in the presence or absence of OY
and fermented OYs for the indicated periods.
Methylthiazolyl tetrazolium (MTT) assay for cell viability
Cytotoxicity was analyzed using an MTT assay. RAW
264.7 cells were seeded at 5 × 10
4 cells/mL densities in
96-well plates (Nunc, Roskilde, Denmark). Each group
had a nontreated group as a control. OY or fermented
OYs (10, 100, 500 and 1000 μg/mL) was added to each
well and incubated for 48 hours at 37°C and 5% CO2.
The MTT solutions (5 mg/mL) were added to each well
and the cells were cultured for another 4 hours. The
supernatant was then discarded and 100 μL of dimethyl
sulfoxide (DMSO) was added to each well. The absor-
bance at 570 nm was read using ELISA reader.
Measurement of NO production
NO production was analyzed by measuring the nitrite
formed in the supernatants of cultured RAW 264.7 cells.
The cells were seeded at 5 × 10
5 cells/mL in 96-well cul-
ture plates. After preincubation of the RAW 264.7 cells for
18 hours, the cells were pretreated with OY or fermented
OYs (10, 100 and 500 μg/mL) and stimulated with LPS
(200 ng/mL) for 24 hours. The supernatant was mixed
with an equal volume of Griess reagent (1% sulfanilamide,
0.1% naphthylethylenediamine dihydrochloride, and 2.5%
phosphoric acid) and incubated at room temperature for 5
min. The concentrations of nitrite were measured by read-
ing at 570 nm. Sodium nitrite (NaNO2) was used to gener-
ate a standard curve.
Measurement of PGE2 production
The RAW 264.7 cells were cultured in 24-well culture
plates (5 × 10
5 cells/mL). The cells were pretreated with
OY or fermented OYs (10, 100 and 500 μg/mL) and sti-
mulated with LPS (200 ng/mL) for 24 hours. The super-
natant was collected for PGE2 d e t e r m i n a t i o nb yaP G E 2
Express EIA Kit (Cayman chemical, Ann Arbor) accord-
ing to the manufacturer’s instructions.
Enzyme-linked immunosorbent assay (ELISA)
Cells were seeded at 5 × 10
5 cells/mL per well in 24-
well culture plates and pretreated with various concen-
trations of OY or fermented OYs (10, 100 and 500 μg/
mL) for 30 min before LPS stimulation (200 ng/mL).
ELISA plates (Nunc, Roskilde, Denmark) were coated
overnight at 4°C with anti-mouse TNF-a or IL-6 antibo-
dies diluted in coating buffer (0.1 M carbonate, pH 9.5)
and then washed four times with PBS containing 0.05%
Tween 20. The nonspecific protein binding sites were
blocked with assay diluent (PBS containing 10% fetal
bovine serum, pH 7.0) for at least 1 hour. Immediately,
each samples and standards were added to the wells.
After incubation for 2 hours, a working detector (bioti-
nylated anti-mouse TNF-a or IL-6 monoclonal antibody
and streptavidin-horseradish peroxidase reagent) was
added and incubated for 1 hour. Subsequently, substrate
solution (tetramethylbenzidine) was added to the wells
and incubated for 30 min in the dark until the reaction
was stopped with stop solution (2 N H3PO4). The absor-
bance at 450 nm was read. All subsequent steps took
place at room temperature and all standards and sam-
ples were assayed in duplicate.
Western blot analysis
Protein expression was assessed by Western blot analysis
according to standard procedures. The RAW 264.7 cells
were cultured in 60-mm-diameter culture dishes (1.5 ×
10
6 cells/mL) and pretreated with OY or fermented OYs
(500 μg/mL). After 30 min, LPS (200 ng/mL) was added
to the cells and the cells were incubated at 37°C for the
indicated periods. After incubation, the cells were washed
twice in ice-cold PBS (pH 7.4). The cells were resus-
pended in lysis buffer containing 50 mM Tris-base (pH
7 . 5 ) ,1 5 0m MN a C l ,2m ME D T A ,1 %g l y c e r o l ,1 0m M
NaF, 10 mM Na-pyrophosphate, 1% NP-40 and protease
inhibitors (0.1 mM phenylmethylsulfonylfluoride, 5 μg/
mL aprotinin, and 5 μg/mL leupeptin) on ice for 15 min,
and cell debris was removed by centrifugation. The pro-
tein concentrations were determined using the Bio-Rad
protein assay reagent (Bio-Rad Laboratories, Hercules,
CA, USA) according to the manufacturer’si n s t r u c t i o n s .
Equal amounts of protein (20 μg) were subjected to
sodium dodecyl sulfate- polyacrylamide gel electrophor-
esis (SDS-PAGE) and then transferred onto a polyvinyli-
dene membrane (Millipore, Bedford, MA, USA). The
membrane was blocked with 5% nonfat milk in Tris-buf-
fered saline (150 mM NaCl, 20 mM Tris-HCl, pH 7.4)
with 0.05% Tween 20 buffer. After blocking, the mem-
brane was incubated with primary antibodies against
COX-2, iNOS, ERK, phospho-ERK, p38, phospho-p38,
JNK and phospho-JNK for 18 hours at 4°C. The mem-
brane was then washed with Tris-buffered saline contain-
ing Tween 20 and incubated with anti-mouse or anti-
rabbit immunoglobulin G horseradish peroxidase (HRP)-
conjugated secondary antibodies. The specific proteins
were detected using enhanced chemiluminescence (ECL)
(Millipore, Billerica, MA, USA).
Preparation of cytosolic and nuclear proteins for IBa
and NF-B
The RAW 264.7 cells pretreated with OY or fermented
OYs were stimulated with LPS (200 ng/mL). For the
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follows. The cells were washed twice in cold PBS, incu-
bated on ice for 10 min in lysis buffer [25 mmol/L Tris-
HCl (pH 7.4), 150 mmol/L NaCl, 1 mmol/L CaCl2,1 %
Triton X-100, 1 mmol/L phenylmethylsulfonyl fluoride,
and 10 μL/mL aprotinin], and centrifuged at 15,000 g
for 10 min at 4°C. To prepare the nuclear fractions, the
cells were washed with 1 mL of ice-cold PBS, resus-
pended in 400 μL of ice-cold hypotonic buffer [10
mmol/L HEPES/KOH, 10 mmol/L KCl, 2 mmol/L
MgCl2, 0.1 mmol/L EDTA, 1 mmol/L dithiothreitol, and
0.5 nmol/L phenylmethylsulfonyl fluoride (pH 7.9)], left
on ice for 10 min, vortex-mixed, and centrifuged at
15,000 g for 30 sec. The pellets were resuspended in 50
μL of ice-cold saline buffer [50 mmol/L HEPES/KOH,
50 mmol/L KCl, 1 mmol/L dithiothreitol, 300 mmol/L
NaCl, 0.1 mmol/L EDTA, 10% glycerol, and 0.5 mmol/L
phenylmethylsulfonyl fluoride (pH 7.9)], left on ice for
20 min, vortex-mixed, and centrifuged at 15,000 g for 5
min at 4°C to collect the supernatant containing the
nuclear fractions. The cytosolic and nuclear fractions
were used to detect IBa or NF-Bv i aW e s t e r nb l o t
analysis as described previously.
RNA extraction and reverse transcription-polymerase
chain reaction (RT-PCR)
Total cellular RNA was isolated by the easy-BLUE™
RNA extraction kit (iNtRON Biotech) according to the
manufacturer’s instructions. The total RNA (2 μg) was
converted to cDNA using 200 units of reverse transcrip-
tase and 500 ng of oligo(dT) primer in 50 mM Tris-HCl
(pH 8.3), 75 mM KCl, 3 mM MgCl2, 10 mM dithiothrei-
tol, and 1 mM deoxynucleotide triphosphates at 42°C
for 1 hour. The reaction was stopped by heating at 70°C
for 15 min, and the cDNA mixture (3 μL) was used for
enzymatic amplification. PCR was performed in 50 mM
KCl, 10 mM Tris-HCl (pH 8.3), 1.5 mM MgCl2,0 . 2
mM deoxynucleotide triphosphates, 2.5 units of Taq
DNA polymerase, and 0.1 μMe a c hT N F - a,I L - 6 ,C O X -
2, iNOS, and b-actin primers, respectively. PCR for
TNF-a and COX-2 was conducted by subjecting the
reaction mixtures to initial denaturation at 94°C for 5
min and followed by 35 cycles of 94°C for 30 sec, 65°C
(TNF-a) ,5 0 ° C( C O X - 2 )f o r3 0s e ca n d7 2 ° Cf o r1m i n ,
with a final extension at 72°C for 7 min [22]. PCR for
IL-6 was conducted by heating the reaction mixtures to
94°C for 3 min, after which they were subjected to 35
cycles of 93°C for 45 sec, 57°C for 45 sec and 72°C for
90 sec, with a final extension at 72°C for 7 min [23].
PCR for iNOS was conducted by heating the reaction
mixtures to 94°C for 5 min, after which they were sub-
jected to 35 cycles of 94°C for 30 sec, 60°C for 30 sec
and 72°C for 1 min, with a final extension at 72°C for 7
min [24]. PCR products were electrophoresed on 1.5%
agarose gel and stained with ethidium bromide. The pri-
mer sequences are listed in Table 1.
High-performance liquid chromatography analysis and
sample preparation
The analytical HPLC system (Hitachi Co., Tokyo,
Japan) consisted of a pump (L-2130), an autosampler
(L-2200), a column oven (L-2350) and a diode array
UV/VIS detector (L-2455). All operations and data
analyses were controlled using Hitachi EZchrom Elite
software. The separation of OY, OY-A and OY-B were
carried out at 40°C on a J’sphere ODS-H80 column
(4.6 mm × 250 mm, 4 μm, YMC Co., Ltd., Kyoto,
Japan). The mobile phases consisted of 0.1% acetic
acid in deionized water (A) and 0.1% acetic acid in
acetonitrile (B) using a gradient elution of 10-10% (v/
v) B at 0-10 min; 10-100% B at 10-60 min; 100-100% B
at 60-70 min. The flow rate was 1.0 mL/min and the
injection volume of samples was 10 μL. Components
were identified via comparison of their retention times
to those of authentic standards under identical analysis
conditions and UV spectra with an in-house PDA-
library. The standard stock solutions of poncirin,
hesperidin, glycyrrhizin, rutin and naringin were pre-
pared in methanol at a concentration of 100 μg/mL.
OY, OY-A and OY-B powder was weighed and dis-
solved with deionized water at a concentration of 20
mg/mL. Prior to analysis, all solutions were maintained
at 4°C and the samples were filtered through a 0.45
μm filter.
Statistical analysis
The results were expressed as means ± SE values for the
number of experiments. Statistical significance was deter-
mined between treated group and the control and was cal-
culated by Student’s t tests. Each experiment was repeated
at least three times to yield comparable results. Values of
P < 0.05 and P < 0.005 were considered significant.
Table 1 Primers used for RT-PCR
Target gene primer sequence
TNF-a F: 5’-AGCCCACGTCGTAGCAAACCACCAA-3’
R: 5’-AACACCCATTCCCTTCACAGAGCAAT-3’
IL-6 F: 5’-CATGTTCTCTGGGAAATCGTGG-3’
R: 5’-AACGCACTAGGTTTGCCGAGTA-3’
COX-2 F: 5’-TTTGATTAGTACTGTAGGGTTAATG-3’
R: 5’-TTTGATTAGTACTGTAGGGTTAATG-3’
iNOS F: 5’-CCTCCTCCACCCTACCAAGT-3’
R: 5’-CACCCAAAGTGCTTCAGTCA-3’
b-actin F: 5’-TGGAATCCTGTGGCATCCATGAAA-3’
R: 5’-TAAAACGCAGCTCAGTAACAGTCCG-3’
F, forward; R, reverse
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Effect of OY and fermented OYs on NO and PGE2
productions by LPS stimulation
First of all, to investigate the anti-inflammatory effect of
OY and fermented OYs, we examined the effect of OY
and fermented OYs on the NO or PGE2 production by
LPS stimulation in RAW 264.7 cells. The cells were pre-
treated with OY or fermented OYs in different concen-
trations before LPS stimulation and subjected to
measure NO production. As a positive control, we used
10 μM dexamethasone, which is used for anti-inflamma-
tory agent. As shown in Figure 1A, non-fermented origi-
nal form, OY did not show any inhibitory effect on NO
production at any concentration but its fermented
forms, both OY-A and OY-B at a concentration of 10
μg/mL inhibited more than 25% of NO production and
their inhibitory effects were increased dose-dependently.
At a concentration of 500 μg/mL, fermented OYs
reduced NO production up to 40%. In addition, when
LPS-stimulated PGE2 secretion was compared in the
presence of OY or fermented OYs, OY and fermented
OYs at a low concentration showed a little inhibitory
effect but fermented OYs repressed more significantly
PGE2 secretion at a high concentration (500 μg/mL)
(Figure 1B).
The fermented OYs suppress TNF-a and IL-6 expression
in LPS-stimulated RAW 264.7 cells
Since original OY showed little effect on NO and PGE2
production but fermented OYs exhibited elevated inhibi-
tory effect on them, we further investigated the effect of
OY and fermented OYs on LPS-stimulated TNF-a and
IL-6 production using ELISA and RT-PCR. The cells
were pretreated with OY or fermented OYs in various
concentrations and subjected to measure the levels of
TNF-a and IL-6 induced by LPS treatment. Likewise,
we used 10 μM dexamethasone as a positive control. As
s h o w ni nF i g u r e2 A ,n o n - f e r m e n t e dO Ys h o w e ds l i g h t
inhibitory effect on TNF-a production but in the pre-
sence of 500 μg/mL fermented OY-A or OY-B, TNF-a
cytokine production was reduced more than 35% com-
pared to untreated control. Next, we examined the effect
of OY and fermented OYs on TNF-a gene expression.
The fermented OYs showed much elevated suppressive
effect on TNF-a mRNA expression than original OY
(Figure 2B). We checked other cytokine IL-6 level in the
presence of OY or fermented OYs. As shown in Figure
3A, consistent with TNF-a result, fermented OY-A and
OY-B at a concentration of 500 μg/mL inhibited IL-6
cytokine production more than 51% and 61%, respec-
tively. Also, fermented OYs showed more significantly
inhibited IL-6 mRNA expression than original OY
Figure 1 Effect of OY and fermented OYs on LPS-induced (A)
NO and (B) PGE2 production. RAW 264.7 cells pretreated with the
indicated each concentration of OY or fermented OYs for 30 min
before being incubated with LPS (200 ng/mL) for 24 hours. The
culture supernatant was analyzed for nitrite production. The data
are mean ± SE values of duplicate determinations from three
separate experiments. *p < 0.05 and **p < 0.005, compared with
LPS-stimulated values.
Figure 2 Effect of OY and fermented OYs on LPS-induced (A)
TNF-a cytokine and (B) mRNA expression. RAW 264.7 cells
pretreated with the indicated concentrations of OY or fermented
OYs for 30 min before being incubated with LPS (200 ng/mL) for
(A) 24 hours and (B) 6 hours, respectively. The level of TNF-a was
measured by ELISA and the mRNA level was assessed by RT-PCR.
(A) The data are mean ± SE values of duplicate determinations from
three independent experiments. *p < 0.05 and **p < 0.005, were
calculated from comparing with LPS-stimulated values. (B) The
values in the LPS-stimulated cells without OY treatment was set to
1.0 and the differences by treatment were quantitated. The
experiments were repeated at least three times, and similar results
were obtained.
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mentation exhibits elevated inhibitory activity on the
inflammatory cytokine expression in transcriptional
level.
The OY and fermented OYs inhibit LPS-stimulated COX-2
and iNOS expressions
Next, we investigated to determine whether the inhibi-
tory effects of fermented OYs on PGE2 and NO produc-
tion are related to the modulation of their synthesizing
enzymes COX-2 and iNOS expression. Usually, in unsti-
mulated cells, COX-2 and iNOS proteins are undetect-
able, but in response to immunostimulators like LPS,
COX-2 and iNOS genes are strongly induced. As shown
in Figure 4A, OY showed weak inhibitory effect on both
protein and mRNA expression of COX-2 but fermented
OYs strongly suppressed COX-2 protein and mRNA
expression at a concentration of 500 μg/mL. Also, when
iNOS expression was compared in the presence of OY
or fermented OYs, consistent with COX-2 results, the
fermented OYs, both OY-A and OY-B strongly inhibited
iNOS protein and mRNA expression (Figure 4B). These
results indicate fermented OYs repress both COX-2 and
iNOS gene expression in mRNA and protein levels,
thereby inhibiting NO and PGE2 production.
Inhibitory effect of OY and fermented OYs on LPS-
induced NF-B nuclear translocation and IBa
degradation
The activation of NF-B is necessary for the induction
of the iNOS and COX-2 genes. Since p65 translocation
is an indicator of NF-B activation by LPS stimulation,
we checked the protein levels of p65 in the nuclear and
cytoplasmic fractions using Western blot analysis. As
shown in Figure 5A, the LPS-induced nuclear transloca-
tion of p65 was a little inhibited by non-fermented OY,
but fermented OYs significantly increased the inhibitory
effect on nuclear translocation of p65 at a concentration
of 500 μg/mL. TATA box-binding protein (TBP) was
used as a loading control in the nuclear protein. Since
the nuclear translocation of p65 is occurred by IBa
phosphorylation and degradation, we also examined the
cytoplasmic levels of IBa and phosphorylated IBa to
check whether the inhibition of p65 translocation by fer-
mented OYs is related with IBa degradation. Figure 5B
represents both OY and fermented OYs block the phos-
phorylation of IBa in the cytosol, implying OYs pre-
vent IBa degradation and NF-B activation.
Effect of OY and fermented OYs on phosphorylation of
MAPKs in LPS-stimulated RAW 264.7 cells
The MAPKs play a critical role in cell proliferation, dif-
ferentiation and cellular responses on cytokines or stress
inducer. Since MAPK activation by phosphorylation are
well-known for NF-B stimulation [25], we investigated
whether the elevated inhibition of NF-B activation by
Figure 3 Effect of OY and fermented OYs on LPS-induced (A)
IL-6 cytokine and (B) mRNA expression. RAW 264.7 cells
pretreated with the indicated each concentrations of OY or
fermented OYs for 30 min were stimulated with LPS (200 ng/mL)
for (A) 24 hours and (B) 6 hours, respectively. The cytokine and
mRNA levels were evaluated by same methods as described in
Figure 2.
Figure 4 Effect of OY and fermented OYs on LPS-induced (A)
COX-2 and (B) iNOS expression. RAW 264.7 cells pretreated with
OY or fermented OYs (500 μg/mL) for 30 min before being
incubated with LPS (200 ng/mL) for 24 hours. Equal amounts of
protein were used for immunoblot analysis for detection of COX-2
and iNOS. RT-PCR was used for COX-2 and iNOS mRNAs analysis.
Oh et al. BMC Complementary and Alternative Medicine 2012, 12:17
http://www.biomedcentral.com/1472-6882/12/17
Page 6 of 10fermented OYs is mediated by the MAPKs pathway.
When we examined the effect of OY and fermented
OYs on the phosphorylation of three MAPKs in LPS-sti-
mulated RAW 264.7 cells using Western blot analysis,
non-fermented OY showed a little inhibitory effect on
phosphorylation of MAPKs, but fermented OYs signifi-
cantly suppressed all MAPKs phosphorylation at 500
μg/mL LPS stimulation (Figure 6). The amounts of non-
phosphorylated MAPKs were not affected by either LPS
or OY and fermented OYs treatments. These results
indicate fermentation of OY by Lactobacillus augments
its repressive effect on MAPK activation by LPS.
High performance liquid chromatography (HPLC) analysis
of OY and fermented OYs
HPLC was used to analyse major marker compounds (1-5)
contained in OY, OY-A and OY-B (Figure 7). HPLC ana-
lysis chromatograms identified that major constituents of
these samples were rutin (tR 20.68 min), naringin (tR 23.20
min), hesperidin (tR 23.74 min), and poncirin (tR 27.81
min) (Figure 8). Glycyrrhizin (tR 34.14 min) was weakly
detected in OY, but disappeared in both OY-A and OY-B.
Five unknown compounds were increased in the fermen-
ted OYs. The structures and identifications of these con-
stituents (1-5) will be elucidated in further study.
Discussion
Many recent studies on natural herb-derived agents
have been investigated to discover the potential anti-
inflammatory natural products using in vitro and in vivo
systems. OY is one of important oriental medicine and
has been used to treat various diseases such as arthralgia
and circulatory disturbance.
Fermentation occurred by microorganism generates
various low molecular weight substances from macro-
molecule like glycoside. Several studies showed
Figure 5 Effect of OY and fermented OYs on LPS-induced (A)
NF-B translocation and (B) IBa degradation. The cells treated
with LPS (200 ng/mL) alone or with LPS and OY and fermented OYs
(500 μg/mL) for 30 min (IBa) or for 1 hour (NF-B). The levels of
IBa and NF-B (p65) in the nuclear and cytosol extracts were
determined by Western blot analysis.
Figure 6 Effect of OY and fermented OYs on LPS-induced the
phosphorylation of MAPKs. RAW 264.7 cells treated with OY or
fermented OYs (500 μg/mL) for 30 min were activated with LPS
(200 ng/mL) for 30 min. Whole-cell lysates were prepared for
detection of MAP kinases in Western blot analysis.
Figure 7 The HPLC analysis chromatograms of OY, OY-A and
OY-B.( A) 280 nm and (B) 335 nm; Increased peaks (1-5) were not
identified; 1. tR 4.11 min; 2. tR 6.17 min; 3. tR 9.13 min; 4. tR 11.50
min; 5. tR 12.03 min.
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the antioxidant activity of original raw materials [5,9]. In
this study, we investigated whether the fermentation by
Lactobacillus affects the composition of OY and
improves anti-inflammatory effect of OY.
Because the overproduction of NO can be harmful
and results in various inflammatory and autoimmune
diseases [26,27], pharmacological interference of the NO
production cascade presents a promising strategy for
therapeutic intervention in inflammatory disorders. In
this study, we demonstrated that the fermented OYs
inhibited more effectively LPS-induced NO and PGE2
production than non-fermented OY. To explore the
inhibitory mechanism of OY and fermented OYs on NO
and PGE2 production in RAW 264.7 cells, we examined
the effect of OY and fermented OYs on the iNOS and
COX-2 genes which are induced in response to inflam-
matory signals such as cytokines and stimuli [28]. OY
s h o w e dal i t t l ei n h i b i t o r ye f f e c to nC O X - 2a n di N O S
expression, but fermented OY-A and OY-B strongly
suppressed COX-2 and iNOS expression in both protein
and mRNA levels. These results imply that fermentation
of OY increases its inhibitory roles on the expression of
pro-inflammatory mediators. When the cytotoxic effect
of OY and fermented OYs was evaluated using an MTT
assay, OY and fermented OYs did not affect the viability
of the RAW 264.7 cells up to concentration of 500 μg/
mL (Figure 9). Therefore, we selected 10-500 μg/mL of
OY and fermented OYs to examine dose-dependent
effect on NO, PGE2 and cytokine production. Also, we
used OY and fermented OYs at 500 μg/mL for Western
blot and RT-PCR analysis.
NF-B is a major regulatory transcription factor
involved in the cellular responses to stimuli such as
stress, cytokines, free radicals, ultraviolet irradiation, oxi-
dized LDL, bacterial or viral antigens [29-33]. In addi-
tion, it is well known that NF-B plays an important
role in the regulation of cell survival and the expression
of pro-inflammatory cytokines [34-38].
Since the expression of these pro-inflammatory media-
tors is modulated by activated NF-B, we investigated
whether OY or fermented OYs inhibit NF-B activation.
We found that fermented OYs not OY strongly repress
both COX-2 and iNOS expression. We also demon-
strated that the nuclear translocation of p65 upon LPS
stimulation was little inhibited by non-fermented OY,
but fermented OYs showed significantly increased inhi-
bition effect on nuclear translocation of p65 through the
elevated phosphorylation of IBa, following to degrada-
tion. These findings are consistent with other studies,
which found that NF-B response elements are present
on the promoter of the COX-2, iNOS, TNF-a and IL-6
genes [39-42].
There are at least three families of MAPKs (ERK,
p38 and JNK MAPKs) which play a critical role in the
LPS-induced iNOS expression signaling pathway [43]
in mammalian cells. We also checked the effect of OY
and fermented OYs on the LPS-induced MAPKs phos-
phorylation in RAW 264.7 cells. Non-fermented OY
showed a little inhibitory effect on the phosphorylation
of ERK 1/2 out of MAPKs but the fermented OYs sig-
nificantly inhibited the levels of phosphorylation of all
MAPKs upon LPS stimulation. These findings suggest
that the enhanced anti-inflammatory activity of fer-
mented OYs is related with repressed NF-Ba n d
MAPK activity.
Conclusions
Taken together these results, OY showed a slight inhibi-
tory effect on the LPS-induced production of pro-
inflammatory mediators, but OYs fermented by Lactoba-
cillus exerted potent anti-inflammatory activity through
inhibiting the production of pro-inflammatory mediators
including NO, PGE2,T N F - a and IL-6 and their synth-
esis enzymes iNOS and COX-2. Consistent with that,
the activities of transcription factor NF-Ba n dM A P K s
Figure 8 Chemical structures of five marker constituents in OY,
OY-A and OY-B.
Figure 9 Assessment of OY and fermented OYs cytotoxicity in
RAW 264.7 cells. The MTT assay was performed after incubation of
RAW 264.7 cells treated with different doses (10, 100, 500 and 1000
μg/mL) of OY or fermented OYs for 48 h. Data are mean ± SE value
of duplicate determinations from three separate experiments.
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Page 8 of 10related with inflammation were also strongly inhibited
by fermented OYs.
In conclusion, OY contains weak anti-inflammatory
activity, but OY-A and OY-B fermented by Lactobacillus
exert remarkably enhanced anti-inflammatory activity
than original form on stimulated macrophage cells.
Based on the HPLC results, the experiments on which
components of OY are modified during fermentation
and responsible for the increased activity are in pro-
gress. These results suggest the OY-A and OY-B could
be developed as a new anti-inflammatory therapeutic
herbal medicine without cytotoxicity after further in
vivo studies.
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